High materiality8/10
AbbVie price target raised to $303 from $298 at Piper Sandler
Why it may matterVerify against the original reporting
Bullish: upside target well above current price.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
ABBV received an analyst target update from Piper Sandler.
- Target: $303 (from $298)
- Current price: $265.97
Key facts
- 01
Target: $303
- 02
Posted price: $265.97
- 03
Analyst firm: Piper Sandler
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.